Dr. Reddy's Laboratories Launches Finrid In India

Dr. Reddy's Laboratories launched Finrid (Fentanyl Transdem Patch) in India. It is used to treat severe to moderate pain, and provides continuous systemic delivery of Fentanyl, a potent opioid analgesic for up to 72 hours. It is the first opioid transdermal patch to be developed in India.

Being a controlled substance, Finrid will be sold through an independent distribution structure and will be available across hospitals and palliative care centers in India. Finrid is available in a transdermal patch form, and delivers dosages of 25 meg/hr and 50 mcg/hr depending on the patch used.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com